Hallet Julie, Cunha Antonio Sa, Adam Rene, Goéré Diane, Azoulay Daniel, Mabrut Jean-Yves, Muscari Fabrice, Laurent Christophe, Navarro Francis, Pessaux Patrick
Institut Hospitalo-Universitaire (IHU), Institute for Minimally Hybrid Invasive Image-Guided Surgery, Université de Strasbourg, Strasbourg, France.
Institut de Recherche sur les Cancers de l'Appareil Digestif (IRCAD), Strasbourg, France.
Ann Surg Oncol. 2016 Dec;23(Suppl 5):894-903. doi: 10.1245/s10434-016-5506-7. Epub 2016 Aug 29.
Recurrence remains frequent after curative-intent hepatectomy for colorectal liver metastases (CRLM). We sought to define short- and long-term outcomes, and identify prehepatectomy factors associated with survival, following rehepatectomy (RH) for recurrence.
We conducted a multi-institutional cohort study of hepatectomy for CRLM over 2006-2013. Second-stage resections were excluded. Primary outcomes were overall survival (OS) and recurrence-free survival (RFS) assessed using Kaplan-Meier methods. Secondary outcomes included 30-day overall morbidity and mortality, and survival from recurrence. Outcomes of RH and initial hepatectomy (IH) were compared.
Of 2771 hepatectomies included in the study, 447 were RH. Median operative time, 30-day morbidity, mortality, and median length of stay did not differ for RH and IH. Five-year OS did not statistically differ, i.e. 56.5 % from RH and 67.6 % from IH [adjusted hazard ratio (HR) 0.9, 95 % confidence interval (CI) 0.5-1.7], and 5-year RFS was inferior after RH (18.5 vs. 28.8 %; adjusted HR 1.3, 95 % CI 1.0-1.7). In patients who eventually recurred, 5-year survival from the time of recurrence did not differ whether it was after RH (46.5 %) or after IH (60.3 %) (adjusted HR 1.1, 95 % CI 0.8-1.8). Rectal primary tumor (HR 1.4, 95 % CI 1.0-2.1) and metastasis ≥3 cm (HR 1.3, 95 % CI 1.1-2.7) were independently associated with RFS, but not OS, after RH.
Short-term outcomes of RH did not differ from IH. While recurrence was more frequent after RH than IH, it did not impact OS. Survival from the time of recurrence did not differ whether recurrence occurred after RH or after IH. CRLM recurrence can be treated with curative intent with excellent long-term outcomes.
结直肠癌肝转移(CRLM)行根治性肝切除术后复发仍然常见。我们试图明确再次肝切除(RH)治疗复发后的短期和长期结局,并确定与生存相关的肝切除术前因素。
我们对2006年至2013年期间行CRLM肝切除术的患者进行了一项多机构队列研究。排除二期切除术。主要结局为采用Kaplan-Meier方法评估的总生存期(OS)和无复发生存期(RFS)。次要结局包括30天总发病率和死亡率以及复发后的生存期。比较了RH和初次肝切除术(IH)的结局。
该研究纳入的2771例肝切除术中,447例为RH。RH和IH的中位手术时间、30天发病率、死亡率及中位住院时间无差异。5年OS无统计学差异,即RH组为56.5%,IH组为67.6%[调整后风险比(HR)0.9,95%置信区间(CI)0.5 - 1.7],RH术后5年RFS较差(18.5%对28.8%;调整后HR 1.3,95%CI 1.0 - 1.7)。在最终复发的患者中,复发后5年生存期在RH后(46.5%)和IH后(60.3%)无差异(调整后HR 1.1,95%CI 0.8 - 1.8)。直肠原发性肿瘤(HR 1.4,95%CI 1.0 - 2.1)和转移灶≥3 cm(HR 1.3,95%CI 1.1 - 2.7)与RH术后的RFS独立相关,但与OS无关。
RH的短期结局与IH无差异。虽然RH后复发比IH更频繁,但不影响OS。复发后的生存期在RH后或IH后复发时无差异。CRLM复发可以采用根治性治疗,长期结局良好。